ACA
BCAB icon

Acorn Capital Advisors’s BioAtla BCAB Stock Holding History

Acorn Capital Advisors’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$865K Buy
108,127
+11,425
+12% +$134K 0.25% 21
2025
Q4 		$2.76M Hold
96,702
– – 0.93% 17
2025
Q3 		$3.34M Hold
96,702
– – 1.69% 14
2025
Q2 		$1.91M Buy
96,702
+16,061
+20% +$326K 1.25% 16
2025
Q1 		$1.41M Hold
80,641
– – 0.94% 19
2024
Q4 		$2.38M Buy
+80,641
New +$6.77M 1.28% 19

Other funds holding BCAB

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Acorn Capital Advisors's BCAB Position: Q1 2026 in Review

Acorn Capital Advisors increased its BioAtla (BCAB) stake by 12% in Q1 2026, buying an estimated $134K and bringing the position to 108,127 shares worth $865K. The position accounts for 0.25% of the portfolio, ranked #21.

Acorn Capital Advisors first reported a position in BCAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.34M in Q3 2025. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • Acorn Capital Advisors held 108,127 shares of BioAtla worth $865K as of Q1 2026.
  • Acorn Capital Advisors bought 11,425 BioAtla shares in Q1 2026, an estimated $134K.
  • BioAtla made up 0.25% of Acorn Capital Advisors's portfolio in Q1 2026, its #21 holding.
  • Acorn Capital Advisors first reported a position in BioAtla in Q4 2024 and has held it in 6 quarters since.
  • Acorn Capital Advisors's BioAtla position peaked at $3.34M in Q3 2025.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on Acorn Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.